Related Experiment Video
Updated: Dec 5, 2025
09:58
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
23.1K
Allergen bronchoprovocation test: an important research tool supporting precision medicine
Louis-Philippe Boulet1, Andréanne Côté1, Khalid Abd-Elaziz2
1Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec Heart and Lung Institute, Université Laval, Québec, Canada.
Current Opinion in Pulmonary Medicine
|October 16, 2020
Summary
The Allergen Bronchoprovocation Test (ABT) advances precision medicine in asthma by identifying allergen-triggered pathways. This aids in understanding asthma phenotypes and evaluating new targeted treatments for personalized patient care.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma is a complex respiratory condition with diverse phenotypes and endotypes.
- The Allergen Bronchoprovocation Test (ABT) is a crucial tool for studying asthma pathophysiology.
- ABT serves as a disease-modeling system for evaluating novel asthma therapeutics.
Purpose of the Study:
- To discuss the role of ABT in precision medicine for asthma.
- To guide clinicians in interpreting ABT data for asthma treatment benefits.
- To review the current applications and recent advancements in ABT.
Main Methods:
- Review of existing literature on ABT applications.
- Integration of ABT with airway sampling techniques (non-invasive and invasive).
- Utilizing innovative detection methods to study inflammatory mechanisms.
Main Results:
- ABT has significantly contributed to defining allergen-induced inflammatory pathways.
- Studies using ABT have elucidated key aspects of allergen-driven asthma phenotypes and endotypes.
- ABT facilitates the assessment of novel targeted asthma treatments.
Conclusions:
- ABT is a valuable research instrument in the era of precision medicine.
- ABT enhances the understanding of asthma heterogeneity and personalized treatment strategies.
- ABT is instrumental in evaluating the efficacy of targeted asthma therapies.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
2.9K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
01:20Asthma: Pathogenesis and Management
1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
01:26Asthma-II: Pathophysiology and Classification
3.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.8K
01:29Asthma-I: Introduction
3.1K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.1K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
596
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
596